Teva Targets 13th Drug Maker In Zoloft Patent Battle
Israeli generic drug maker Teva Pharmaceutical Industries Ltd. has sued yet another pharmaceutical company in its ongoing patent battle over the exclusive rights to sell a generic version of Pfizer Inc.'s...To view the full article, register now.
Already a subscriber? Click here to view full article